Atlas Trials

Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis

Clinical trial NCT01383603 · COMPLETED

Trial details

NCT number
NCT01383603
Sponsor
Circassia Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cat Allergy
Start date
2011-10-01
Primary completion
2014-05-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.